title: PARADIGM-HF trial: will LCZ696 change the current treatment of systolic heart failure?
authors.affiliation: Cardiology Unit, Medicine Department, Hospital Municipal de Badalona, Spain. E-mail: ejkaplinsky@gmail.com.
authors.forename: Edgardo
authors.initials: E
authors.lastname: Kaplinsky
keywords: Angiotensin receptor blocker; Heart failure; LCZ696